ISPE Company name
ISPE 2024mym

Oral Presentations and Posters

Oral Presentations

Monday, April 15

2:00pm – 3:30pm, Student Oral Session I, Center

  • The life cycle of vaccines evaluated by the European Medicines Agency, Débora Dalmas Gräf (Vaccine)
  • Mental Health Comorbidities as Risk Factors for Cannabinoid Hyperemesis Syndrome: A Pharmacoepidemiological Approach Using Electronic Health Records, Brianna Costales (Safety Outcomes)
  • Antidepressant use during pregnancy and birth outcomes: a triangulation of methods in three countries, Florence Martin (Pregnancy and Lactation)
  • Concurrent use of Cholinesterase Inhibitors and Beta-Blockers and Risk of Fall-Related Injury: a self-controlled case series analysis, Meghan Cupp (Geriatric Pharmacoepidemiology)
  • Shift in Vasopressin Utilization: Adapting to Passive Restrictions Since January 2021, Xiaojiang Guo (Drug Utilization Research)
  • Missing race and ethnicity data in Medicaid: a mixed effects analysis of national and state trends, 2016-2022, Theresa Oduol (Health Equity)

4:00pm – 5:30pm, Student Oral Session II, Center

  • Antiepileptic Drugs and Risk of Cancer: A Meta-Analysis of Observational Epidemiological Studies, Tien Tran Hoang (Safety Outcomes)
  • Exploring the Utility of Real-World Data to Evaluate Bleeding Irregularities Among New Users of Hormonal Contraceptives, Sebastian Jugl (Safety Outcomes)
  • Racial/Ethnic Disparities in Predictors for Sleep Disorder among Alzheimer’s Disease and Related Dementias (ADRD) Patients Using Machine Learning Approach, Xiangxiang Jiang (Health Equity)
  • Impact of 2019 Regulatory Measures on Fluoroquinolone Usage: A Time Series Analysis, Yuchen Guo (Drug Utilization Research)
  • Risk of Acute-Kidney Injury in Hospitalized Patients Treated with Short-Courses of Ibuprofen: A Retrospective Cohort Study, Haedi Thelen (Safety Outcomes)
  • Exploring temporal patterns of topiramate utilization in Belgium: trends pre-, during-, and post-pregnancy (2010-2016), Calypse Robinson (Drug Utilization Research)



  1. Assessing the real-world effectiveness of hormonal contraceptives in commercial claims database: a validation study of the contraceptive identification algorithm, Yehua Wang (Pregnancy and Lactation)
  2. Comparing major adverse cardiovascular event risk in Tenofovir Alafenamide versus Tenofovir disoproxil fumarate in pre-exposure prophylaxis or HIV patients, Jyotirmoy Sarker (Safety Outcomes)
  3. Real-World Medication Management of Individuals with Sickle Cell Disease, Abiodun Ologunowa (Drug Utilization Research)
  4. Identifying patient characteristics associated with suboptimal prescribing cascades following treatment with antihypertensive medications, Katherine Crum (Drug Utilization Research)
  5. Secular trends and determinants of use of gabapentin during pregnancy among publicly insured pregnant persons in the United States 2000 to 2015, Rupal Aroza (Drug Utilization Research)
  6. Is critical care admission associated with chronic medication discontinuation after patients' first hospitalisation? A retrospective cohort study, Elizabeth Mansi (Disease Epidemiology / Clinical Course)
  7. unmconf: An R Package for Bayesian Regression with Unmeasured Confounders, Ryan Hebdon (Methods in Pharmacoepidemiology)
  8. Statistical methods to evaluate the impact of public health interventions: An example using interrupted time series and autoregressive moving average models, Yuchen Guo (Drug Utilization Research)
  9. Per-Protocol Analyses of the Systolic Blood Pressure Intervention Trial (SPRINT), Fanxing Du (Methods in Pharmacoepidemiology)
  10. Adverse events among drug users in a hospital setting, are they investigated for their causality? A retrospective study conducted in an academic tertiary care centre in Quebec (Canada), Sonia Corbin (Pharmacovigilance)
  11. Prevalence of rectal prolapse and characterisation of the patients with rectal prolapse in the UK and the US between 2013 to 2021, Abigail Robinson (Disease Epidemiology / Clinical Course)
  12. Pharmaceuticals and Publications: A Comprehensive Bibliometric Study on the Antidepressant Literature, Lukas Westphal (Informatics)
  13. Cost analysis of vasopressin use in patients with septic shock, Stacey Wang (Health Economics / Outcomes Research)
  14. Investigating the Impact of the Second-line Antihypertensive Drugs on Microvascular Diseases in Patients with Concomitant Hypertension and Type 2 Diabetes Mellitus, Qi Jian (BRACE)‎
  15. Early signs and symptoms in patients with Multiple System Atrophy: A comparative study using CPRD, Hosn Nabaa (Rare Disease)
  16. Age and Race-based Disparities in the Impact of Hormone Modulating Therapy for Breast Cancer on Development of Alzheimer’s Disease and Related Dementias, Sophia Knudsen (Geriatric Pharmacoepidemiology)
  17. Serious adverse events at Quebec Heart and Lung Institute - Laval University, are they reported as they should?, Maude Lavallée (Pharmacovigilance)
  18. Driving Factors for Sleep Disorders Among Cancer Patients Using Machine Learning Approach, Xiangxiang Jiang (Health Economics / Outcomes Research)
  19. Effectiveness of Low-Dose Naltrexone in the Treatment of Fibromyalgia: A Systematic Review and Meta-Analysis, Abiodun Ologunowa (Drug Effectiveness)
  20. Utilization of Oral Anticoagulants among Patients with Atrial Fibrillation from 2014 to 2021 in the United States, Jade Bowers (Drug Utilization Research)
  21. Incidence of mortality and the prognostic significance of malnutrition in chronic kidney disease patients: a systematic review and meta-analysis, Ishfaq Rashid Teali (Disease Epidemiology / Clinical Course)
  22. Denosumab and hypocalcaemia: Analysis of the US FDA Adverse Event Reporting System (FAERS), Yu Ren (Safety Outcomes)
  23. Effectiveness and safety of antibiotic prophylaxis in close contacts of invasive group A streptococci infection, Marina Birck (Drug Effectiveness)
  24. Efficacy of IL-1 or IL-6 Inhibitors in Patients with Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analyses, Henry Chen (Pediatric Pharmacoepidemiology)
  25. Evaluating the Accuracy of Responses by Large Language Models for Information on Disease Epidemiology, Kexin Zhu (Methods in Pharmacoepidemiology)
  26. Drug Prescription Patterns and Direct Medical Cost of Inflammatory Bowel Disease (IBD) exacerbation in a tertiary care setting, Karen Martin (Drug Utilization Research)
  27. Chronic Liver Disease is Associated with Greater Risk of Hospital Readmission in Patients with Heart Failure: A Nationwide Database Study in the US, Julia Yang (Disease Epidemiology / Clinical Course)
  28. Considerations to Ensure Transportability When Using Open Claims Data to Conduct Natural History and Event Rate Estimation Studies, Nazha Diwan (Safety Outcomes)
  29. Exploratory Findings on Australian Antimicrobial Stewardship in the Community Setting, Rose Okonkwo (Health Economics / Outcomes Research)
  30. Determinants of and Barriers to Diabetes Care among Patients with Serious Mental Illness: A Scoping Review with Recommendations, Muhammed Rashid (BRACE)‎
  31. An institution based cross sectional study of health insurance and diabetes outcome indicators Adare General Hospital, Hawassa, Ethiopia, Biruk Teshome (Health Economics / Outcomes Research)
  32. Using target trial emulation to estimate the effectiveness of mRNA COVID-19 primary series vaccination among nursing home residents in the United States, Andrew Huang (Geriatric Pharmacoepidemiology)
  33. Evaluating the Impact of Florida's Opioid Restriction Law on Over-the-Counter Analgesic Product Sales, Enyao Zhang (Drug Utilization Research)